Does prehospital administration of ticagrelor improve pre-PCI coronary reperfusion in patients with acute STEMI?
Prehospital administration of ticagrelor in acute STEMI is safe but does not improve pre-PCI coronary reperfusion.
Prehospital administration of ticagrelor in patients with acute STEMI appeared to be safe but did not improve pre-PCI coronary reperfusion. (Funded by AstraZeneca; ATLANTIC ClinicalTrials.gov number, NCT01347580.).
Montalescot et al. (Mon,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: